Predictive Oncology appoints business development veteran Pamela Bush as chief business officerProactive Investors • 02/03/23
Predictive Oncology Appoints Pamela Bush, Ph.D., MBA, as Chief Business OfficerGlobeNewsWire • 02/03/23
Predictive Oncology adds Dr Robert F. Murphy to its scientific advisory boardProactive Investors • 01/12/23
Pioneer of Computational Biology Joins the Scientific Advisory Board of Predictive OncologyGlobeNewsWire • 01/12/23
Predictive Oncology adds Chan Zuckerberg Initiative's Marc Malandro to its scientific advisory boardProactive Investors • 12/13/22
Distinguished Innovator in Genomics Joins the Scientific Advisory Board of Predictive OncologyGlobeNewsWire • 12/13/22
Predictive Oncology adds leading biopharma executive Dr Matthew J Hawryluk to its boardProactive Investors • 12/05/22
Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D.GlobeNewsWire • 12/05/22
Predictive Oncology reports 45% revenue jump, increased gross profit margin in 3QProactive Investors • 11/11/22
Predictive Oncology strengthens board of directors with life sciences and corporate attorney David SmithProactive Investors • 10/25/22
Predictive Oncology appoints biotech veteran Raymond Vennare as its new CEO and chairmanProactive Investors • 10/20/22
Predictive Oncology Announces New Chief Executive Officer Raymond F. Vennare to Lead Company GrowthGlobeNewsWire • 10/20/22
Predictive Oncology strengthens pharmaceutical and biotech offering; announces retirement of CEO and chairman J Melville EngleProactive Investors • 09/19/22
Predictive Oncology Strengthens Offerings with GMP Lab and Addition of Leading Expert in Formulation DevelopmentGlobeNewsWire • 09/19/22
Predictive Oncology announces retirement of its chief executive officer and chairman, J. Melville EngleProactive Investors • 09/19/22
Predictive Oncology ends 2Q 2022 with strong balance sheet and solid cash positionProactive Investors • 08/12/22
Traders News Source Senior Editor Mark Roberts Interviews J. Melville Engle, CEO and Chairman of the Board, Predictive OncologyAccesswire • 08/09/22
Predictive Oncology appoints Julia Kirshner as its new Chief Scientific OfficerProactive Investors • 07/26/22